Bausch Drug Patent Portfolio

Bausch owns 51 orange book drugs protected by 192 US patents with Cardizem Cd having the least patent protection, holding only 1 patent. And Jublia with maximum patent protection, holding 18 patents. Given below is the list of Bausch's drug patents along with their expiration dates.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US11389467	Topical compositions	28 Dec, 2040	Active
US12128059	Topical compositions	31 Jul, 2040	Active
US12133859	Topical compositions	31 Jul, 2040	Active
US12138278	Topical compositions	31 Jul, 2040	Active
US12419833		16 Apr, 2040	Active
US11311482	Topical compositions and methods for treating skin diseases	11 May, 2038	Active
US12128137	Topical compositions and methods for treating skin diseases	11 May, 2038	Active
US10293047	Fluorescein and benoxinate compositions	15 Nov, 2037	Active
US10632197	Fluorescein and benoxinate compositions	15 Nov, 2037	Active
US10842872	Fluorescein and benoxinate compositions	15 Nov, 2037	Active
US10507132	Topical administration method	21 Jun, 2037	Active
US10596107	Ophthalmic suspension composition	23 Dec, 2036	Active
US11357738	Semifluorinated compounds and their compositions	29 Sep, 2036	Active
US11679116	Topical compositions and methods for treating psoriasis	06 Jun, 2036	Active
US10251895	Topical compositions and methods for treating psoriasis	06 Jun, 2036	Active
US10426787	Topical compositions and methods for treating psoriasis	06 Jun, 2036	Active
US11648256	Topical compositions and methods for treating psoriasis	06 Jun, 2036	Active
US11679115	Topical compositions and methods for treating psoriasis	06 Jun, 2036	Active
US11534395	Ophthalmic suspension composition	26 Jan, 2036	Active
US10478601	Applicator	25 Apr, 2035	Active
US10342875	Stabilized efinaconazole compositions	02 Oct, 2034	Active
US10828293	Anti-infective methods, compositions, and devices	02 Oct, 2034	Active
US10864274	Stabilized efinaconazole formulations	02 Oct, 2034	Active
US11654139	Anti-infective methods, compositions, and devices	02 Oct, 2034	Active
US9662394	Stabilized efinaconazole compositions	02 Oct, 2034	Active
US9937075	Apparatus and methods for ocular injection	02 May, 2034	Active
US8980931	Method of evaluating pharmaceutical preparation containing luliconazole and index substance	28 Apr, 2034	Active
US11058677	LFA-1 inhibitor formulations	18 Dec, 2033	Active
US9517220	Bromfenac bioavailability	11 Nov, 2033	Active
US9636332	Methods and devices for the treatment of ocular diseases in human subjects	08 Nov, 2033	Active
US10058615	Semifluorinated alkane compositions	12 Sep, 2033	Active
US10369117	Compositions comprising mixtures of semifluorinated alkanes	12 Sep, 2033	Active
US10449164	Methods of treating ocular disorders using semifluorinated alkanes	12 Sep, 2033	Active
US10576154	Semifluorinated alkane compositions	12 Sep, 2033	Active
US9012484	Crystal and pharmaceutical preparation containing the same crystal	06 Sep, 2033	Active
US9199977	Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal	06 Sep, 2033	Active
US9453006	Crystalline form having specific crystal habit and pharmaceutical composition containing this crystalline form as active ingredient	06 Sep, 2033	Active
US9085553	LFA-1 inhibitor and methods of preparation and polymorph thereof	25 Jul, 2033	Active
US10085958	Bromfenac bioavailability	19 Nov, 2032	Active
US9192615	Method for the treatment of acne and certain dosage forms thereof	17 Nov, 2031	Active
US10478502	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031	Active
US11839656	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031	Active
US11957753	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031	Active
US11986527	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031	Active
US12076403	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031	Active
US8809307	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031	Active
US8481526	Fluoroquinolone carboxylic acid molecular crystals	09 Jan, 2031	Active
US8927574	Crystalline pharmaceutical and methods of preparation and use thereof	12 Nov, 2030	Active
US8415342	Besifloxacin ophthalmic composition for the treatment or control of infection	07 Nov, 2030	Active
US8486978	Compositions and methods for treating diseases of the nail	24 Oct, 2030	Active
US9302009	Compositions and methods for treating diseases of the nail	24 Oct, 2030	Active
US9353088	Crystalline pharmaceutical and methods of preparation and use thereof	21 Oct, 2030	Active
US9890141	Crystalline pharmaceutical and methods of preparation and use thereof	21 Oct, 2030	Active
US8293742	Preferential vasoconstriction compositions and methods of use	14 Jul, 2030	Active
US9259425	Compositions and methods for eye whitening	14 Jul, 2030	Active
US10105444	Compositions and methods for treating diseases of the nail	08 Jul, 2030	Active
US8039494	Compositions and methods for treating diseases of the nail	08 Jul, 2030	Active
US9861698	Compositions and methods for treating diseases of the nail	08 Jul, 2030	Active
US10918635	Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts	30 Apr, 2030	Active
US11202752	Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy	30 Apr, 2030	Active
US11850245	Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts	30 Apr, 2030	Active
US8604020	Fluoroquinolone carboxylic acid molecular crystals	12 Mar, 2030	Active
US10238644	2×2×2 week dosing regimen for treating acting keratosis with pharmaceutical compositions formulated with 3.75% imiquimod	11 Dec, 2029	Active
US11318130	2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75% imiquimod	11 Dec, 2029	Active
US8222270	2×2×2 week treatment regimen for treating actinic keratosis with pharmaceutical compositions formulated with 2.5% imiquimod	11 Dec, 2029	Active
US8236816	2×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod	11 Dec, 2029	Active
US8299109	Method of treating actinic keratosis with 3.75% imiquimod cream	11 Dec, 2029	Active
US8937062	Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria	13 Nov, 2029	Active
US10238645	Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts	18 Aug, 2029	Active
US8598196	Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy	18 Aug, 2029	Active
US8288434	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	05 Aug, 2029	Active
US11596600	Vasoconstriction compositions and methods of use	27 Jul, 2029	Active
US11833245	Vasoconstriction compositions and methods of use	27 Jul, 2029	Active
US10220049	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029	Active
US10624918	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029	Active
US8663699	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029	Active
US8895070	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029	Active
US9078870	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029	Active
US9561208	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029	Active
US10137142	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029	Active
US9504704	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029	Active
US8168655	Compositions and methods for treatment of eye disorders	09 May, 2029	Active
US8367701	Crystalline pharmaceutical and methods of preparation and use thereof	15 Apr, 2029	Active
US9447077	Crystalline pharmaceutical and methods of preparation and use thereof	15 Apr, 2029	Active
US8058467	Prostaglandin derivatives	21 Feb, 2029	Active
US10512640	Compositions and methods for treating diseases of the nail	03 Jan, 2028	Active
US10828369	Compositions and methods for treating diseases of the nail	03 Jan, 2028	Active
US11213519	Compositions and methods for treating diseases of the nail	03 Jan, 2028	Active
US11872218	Compositions and methods for treating diseases of the nail	03 Jan, 2028	Active
US9566272	Compositions and methods for treating diseases of the nail	03 Jan, 2028	Active
US9877955	Compositions and methods for treating diseases of the nail	03 Jan, 2028	Active
US8636713	Methods and devices for drug delivery to ocular tissue using microneedle	02 May, 2027	Active
US7541347	Minocycline oral dosage forms for the treatment of acne	02 Apr, 2027	Active
US7544373	Minocycline oral dosage forms for the treatment of acne	02 Apr, 2027	Active
US7919483	Method for the treatment of acne	07 Mar, 2027	Active
US7378405	Stabilized steroid composition and method for its preparation	19 Dec, 2026	Active
US7241805	Modified release formulations of a bupropion salt	27 Jun, 2026	Active
US7569610	Modified release formulations of a bupropion salt	27 Jun, 2026	Active
US7572935	Modified release formulations of a bupropion salt	27 Jun, 2026	Active
US7585897	Modified release formulations of a bupropion salt	27 Jun, 2026	Active
US7645802	Bupropion hydrobromide and therapeutic applications	27 Jun, 2026	Active
US7649019	Modified release formulations of a bupropion salt	27 Jun, 2026	Active
US7662407	Modified release formulations of a bupropion salt	27 Jun, 2026	Active
US7671094	Bupropion hydrobromide and therapeutic applications	27 Jun, 2026	Active
US8084047	Compositions and methods for treatment of eye disorders	17 May, 2026	Active
US8592450	Compositions and methods for treatment of eye disorders	17 May, 2026	Active
US7214506	Method for treating onychomycosis	22 Feb, 2026	Active
US7273946	Prostaglandin derivatives	03 Oct, 2025	Expired
US8129431	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	11 Sep, 2025	Expired
US7790705	Minocycline oral dosage forms for the treatment of acne	24 Jun, 2025	Expired
US8252776	Minocycline oral dosage forms for the treatment of acne	24 Jun, 2025	Expired
US8268804	Minocycline oral dosage forms for the treatment of acne	24 Jun, 2025	Expired
US8722650	Extended-release minocycline dosage forms	24 Jun, 2025	Expired
US7314938	Modulators of cellular adhesion	10 Mar, 2025	Expired
US7981877	Stabilized steroid composition and method for its preparation	23 Jan, 2025	Expired
US8784789	Aqueous liquid preparations and light-stabilized aqueous liquid preparations	13 Jan, 2025	Expired
US7629345	Prostaglandin derivatives	05 Jan, 2025	Expired
US7910767	Prostaglandin derivatives	05 Jan, 2025	Expired
US10124000	Modulators of cellular adhesion	05 Nov, 2024	Expired
US7745460	Modulators of cellular adhesion	05 Nov, 2024	Expired
US7790743	Modulators of cellular adhesion	05 Nov, 2024	Expired
US7928122	Modulators of cellular adhesion	05 Nov, 2024	Expired
US9216174	Modulators of cellular adhesion	05 Nov, 2024	Expired
US7696159	Treatment for basal cell carcinoma	01 Oct, 2024	Expired
US7696159	Treatment for basal cell carcinoma	01 Apr, 2024	Expired
US8669290	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	16 Jan, 2024	Expired
US8754131	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	16 Jan, 2024	Expired
US8871813	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	16 Jan, 2024	Expired
US8927606	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	16 Jan, 2024	Expired
US9144609	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	16 Jan, 2024	Expired
US9561277	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	16 Jan, 2024	Expired
US8877168	Aqueous liquid preparations and light-stabilized aqueous liquid preparations	30 Jul, 2023	Expired
US8232264	Compositions and methods for enhancing corticosteroid delivery	09 Mar, 2023	Expired
US7220424	Compositions and methods for enhancing corticosteroid delivery	07 Jan, 2023	Expired
US7794738	Compositions and methods for enhancing corticosteroid delivery	11 Sep, 2022	Expired
US6765001	Compositions and methods for enhancing corticosteroid delivery	21 Dec, 2021	Expired
US6685958	Quinolone carboxylic acid compositions and related methods of treatment	29 Jun, 2021	Expired
US7223387	Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester	28 Feb, 2021	Expired
US6923984	Cushioning wax beads for making solid shaped articles	25 Feb, 2021	Expired
US6517847	Topical gel delivery system	03 Aug, 2020	Expired
US6387383	Topical low-viscosity gel composition	03 Aug, 2020	Expired
US5900488	Method for treating mycosis using imidazolylacetonitrile derivatives	18 Jan, 2020	Expired
US7108866	Chronotherapeutic diltiazem formulations and the administration thereof	17 Dec, 2019	Expired
US6780877	Acid addition salt of optically active piperidine compound and process for preparing the same	19 Sep, 2019	Expired
US6261546	Methods and compositions for stabilizing acetylcholine compositions	29 Apr, 2019	Expired
US6699492	Quinolone carboxylic acid compositions and related methods of treatment	31 Mar, 2019	Expired
US6217895	Method for treating and/or preventing retinal diseases with sustained release corticosteroids	22 Mar, 2019	Expired
US6548078	Method for treating and/or preventing retinal diseases with sustained release corticosteroids	22 Mar, 2019	Expired
US6423722	Crystalline macrolides and process for their preparation	26 Dec, 2018	Expired
US6645963	Prolonged-action eye drop	16 Nov, 2018	Expired
US6335335	Prolonged-action eye drop	02 Nov, 2018	Expired
US6096341	Delayed release tablet of bupropion hydrochloride	30 Oct, 2018	Expired
US6423722	Crystalline macrolides and process for their preparation	26 Jun, 2018	Expired
US6211233	Prostaglandin pharmaceutical compositions	17 Jun, 2018	Expired
US5908838	Method for the treatment of acne	19 Feb, 2018	Expired
US6150337	Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes	21 Nov, 2017	Expired
US7981909	Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis	16 Sep, 2017	Expired
US8227490	Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis	16 Sep, 2017	Expired
US5800807	Ophthalmic compositions including glycerin and propylene glycol	29 Jan, 2017	Expired
US6514980	Nucleoside analogs in combination therapy of herpes simplex infections	24 Jan, 2017	Expired
US6011020	Nucleic acid ligand complexes	04 Jan, 2017	Expired
US5912238	Heteroatoms-containing tricyclic compounds	15 Dec, 2016	Expired
US5962731	Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors	05 Oct, 2016	Expired
US5955109	Methods and compositions for topical delivery of retinoic acid	21 Sep, 2016	Expired
US5932462	Multiarmed, monofunctional, polymer for coupling to molecules and surfaces	03 Aug, 2016	Expired
US5912238	Heteroatoms-containing tricyclic compounds	15 Jun, 2016	Expired
US6352998	Pharmaceutical compositions	26 Apr, 2016	Expired
US5447926	Quinolone carboxylic acid derivatives	13 Apr, 2016	Expired
US5756541	Vision through photodynamic therapy of the eye	11 Mar, 2016	Expired
US6423342	Process for the preparation of a solid pharmaceutical dosage form	01 Mar, 2016	Expired
USRE39264	Pharmaceutical combination	02 Feb, 2016	Expired
US6352998	Pharmaceutical compositions	26 Oct, 2015	Expired
US5798349	Use of green porphyrins to treat neovasculature in the eye	25 Aug, 2015	Expired
US5707608	Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer	02 Aug, 2015	Expired
US5780676	Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors	14 Jul, 2015	Expired
US6051698	Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes	19 May, 2015	Expired
US5733886	Compositions of clindamycin and benzoyl peroxide for acne treatment	31 Mar, 2015	Expired
USRE41134	Slow release vehicles for minimizing skin irritancy of topical compositions	24 Feb, 2015	Expired
US5770619	Method of activating photosensitive agents	06 Jan, 2015	Expired
US5648093	Pharmaceutical and other dosage forms	15 Jul, 2014	Expired
US5540930	Suspension of loteprednol etabonate for ear, eye, or nose treatment	25 Apr, 2014	Expired
US5747061	Suspension of loteprednol etabonate for ear, eye, or nose treatment	25 Apr, 2014	Expired
US5919455	Non-antigenic branched polymer conjugates	27 Oct, 2013	Expired
US6113906	Water-soluble non-antigenic polymer linkable to biologically active material	27 Oct, 2013	Expired
US5540930	Suspension of loteprednol etabonate for ear, eye, or nose treatment	25 Oct, 2013	Expired
US5747061	Suspension of loteprednol etabonate for ear, eye, or nose treatment	25 Oct, 2013	Expired
US5462740	Rectally-administered, epileptic-seizure-inhibiting composition	17 Sep, 2013	Expired
US5536743	Intravaginal treatment of vaginal infections with buffered metronidazole compositions	16 Jul, 2013	Expired
US5529791	Extended release form of diltiazem	25 Jun, 2013	Expired
US5476875	Catechol derivatives	19 Dec, 2012	Expired
US4996335	Soft steroids having anti-inflammatory activity	09 Sep, 2012	Expired
US5439689	Diltiazem formulation	08 Aug, 2012	Expired

Latest Legal Activities on Bausch's Drug Patents

Given below is the list of recent legal activities going on the following drug patents of Bausch.

Activity	Date	Patent Number

Withdrawal of Application for PTE Critical	02 Jul, 2024	US8168655
Notice of Final Determination -Eligible	02 Jul, 2024	US7314938
Withdrawal of Application for PTE Critical	02 Jul, 2024	US7790743
Withdrawal of Application for PTE Critical	02 Jul, 2024	US8592450
Withdrawal of Application for PTE Critical	02 Jul, 2024	US8084047
Maintenance Fee Reminder Mailed Critical	10 Jun, 2024	US8293742
Payment of Maintenance Fee, 8th Year, Large Entity	22 May, 2024	US9517220
Payment of Maintenance Fee, 4th Year, Large Entity	21 May, 2024	US10864274
Payment of Maintenance Fee, 4th Year, Large Entity	19 Apr, 2024	US10842872
Payment of Maintenance Fee, 8th Year, Large Entity	18 Apr, 2024	US9504704 (Litigated)
Payment of Maintenance Fee, 4th Year, Large Entity	18 Apr, 2024	US10828293
Payment of Maintenance Fee, 12th Year, Large Entity	20 Mar, 2024	US8288434 (Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity	20 Mar, 2024	US8288434 (Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity	20 Mar, 2024	US8288434 (Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity	20 Mar, 2024	US8299109 (Litigated)

Bausch's Drug Patent Litigations

Bausch's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Sep 26, 1995, against patent number US5955109. The petitioner , challenged the validity of this patent, with WON et al as the respondent. Click below to track the latest information on how companies are challenging Bausch's patents.

Patent	Proceeding Filing Date	Status	Respondent	Petitioner

US11596600	February, 2024	Pending	Eye Therapies, LLC et al.	Dr. Reddy's Laboratories S.A. et al.
US8293742	November, 2021	Terminated-Settled (13 Aug, 2025)	Eye Therapies, LLC et al.	Slayback Pharma LLC et al.
US11833245	January, 2024	Terminated-Settled (22 Jul, 2025)	Eye Therapies, LLC et al.	Dr. Reddy's Laboratories S.A. et al.
US11596600	February, 2024	Terminated-Settled (22 Jul, 2025)	Eye Therapies, LLC et al.	Dr. Reddy's Laboratories S.A. et al.
US11596600	February, 2024	Trial Instituted (10 Sep, 2024)	Eye Therapies, LLC et al.	Dr. Reddy's Laboratories S.A. et al.
US11833245	January, 2024	Trial Instituted (13 Aug, 2024)	Eye Therapies, LLC et al.	Dr. Reddy's Laboratories S.A. et al.
US11311482	June, 2023	Institution Denied (12 Jan, 2024)	Bausch Health Ireland Limited et al.	Padagis Israel Pharmaceuticals Ltd. et al.
US8293742	November, 2021	Final Written Decision - Appealed (15 May, 2023)	Eye Therapies, LLC et al.	Slayback Pharma LLC et al.
US9259425	November, 2021	Terminated-Settled (05 Oct, 2022)	Eye Therapies, LLC	Slayback Pharma LLC
US10596107	January, 2019	Decision (18 Jul, 2019)	Mohannad Shawer et al.
US10449164	April, 2018	Decision (17 Jan, 2019)	Novaliq GmbH
US7214506	November, 2016	FWD Entered (06 Jun, 2018)	Kaken Pharmaceutical Co., Ltd.	Acrux DDS Pty Ltd.
US7214506	November, 2016	Final Written Decision (06 Jun, 2018)	Kaken Pharmaceutical Co., Ltd.	Acrux DDS Pty Ltd. et al.
US7214506	May, 2017	Terminated-Settled (13 Nov, 2017)	Kaken Pharmaceutical Co., Ltd. et al.	Argentum Pharmaceuticals LLC et al.
US8877168	June, 2016	Terminated-Settled (14 Nov, 2016)	Senju Pharmaceuticals Co., Ltd.	Mylan Pharmaceuticals, Inc.
US8754131	November, 2015	FWD Entered (12 Sep, 2016)	SENJU PHARMACEUTICAL CO., LTD.	InnoPharma Licensing, Inc.
US8871813	April, 2015	FWD Entered (12 Sep, 2016)	SENJU PHARMACEUTICAL CO., LTD.	Lupin Ltd.
US8871813	April, 2015	Final Written Decision (12 Sep, 2016)	SENJU PHARMACEUTICAL CO., LTD. et al.	Lupin Ltd. et al.
US8927606	November, 2015	FWD Entered (12 Sep, 2016)	SENJU PHARMACEUTICAL CO., LTD.	InnoPharma Licensing, Inc.
US8754131	April, 2015	FWD Entered (12 Sep, 2016)	SENJU PHARMACEUTICAL CO., LTD.	Lupin Ltd.
US8927606	November, 2015	Final Written Decision (12 Sep, 2016)	SENJU PHARMACEUTICAL CO., LTD. et al.	InnoPharma Licensing, Inc. et al.
US8754131	April, 2015	Final Written Decision (12 Sep, 2016)	SENJU PHARMACEUTICAL CO., LTD. et al.	Lupin Ltd. et al.
US8669290	April, 2015	FWD Entered (12 Sep, 2016)	SENJU PHARMACEUTICAL CO., LTD.	Lupin Ltd.
US8669290	April, 2015	Final Written Decision (12 Sep, 2016)	SENJU PHARMACEUTICAL CO., LTD. et al.	Lupin Ltd. et al.
US8927606	April, 2015	Final Written Decision (12 Sep, 2016)	Senju Pharmaceutical Co., Ltd. et al.	Lupin Ltd. et al.
US8754131	November, 2015	Final Written Decision (12 Sep, 2016)	SENJU PHARMACEUTICAL CO., LTD. et al.	InnoPharma Licensing, Inc.
US8871813	November, 2015	FWD Entered (12 Sep, 2016)	SENJU PHARMACEUTICAL CO., LTD.	InnoPharma Licensing, Inc.
US8871813	November, 2015	Final Written Decision (12 Sep, 2016)	SENJU PHARMACEUTICAL CO., LTD. et al.	InnoPharma Licensing, Inc. et al.
US8927606	April, 2015	FWD Entered (12 Sep, 2016)	Senju Pharmaceutical Co., Ltd.	Lupin Ltd.
US8784789	February, 2016	Terminated-Settled (31 Aug, 2016)	Senju Pharmaceutical Co. Ltd.	Mylan Pharmaceuticals, Inc.
US8129431	September, 2015	Final Written Decision (05 Aug, 2016)	SENJU PHARMACEUTICAL CO., LTD. et al.	Lupin Ltd. et al.
US8129431	September, 2015	FWD Entered (05 Aug, 2016)	SENJU PHARMACEUTICAL CO., LTD.	Lupin Ltd.
US8129431	March, 2015	Final Written Decision (28 Jul, 2016)	Senju Pharmaceutical Co., Ltd. et al.	InnoPharma, Licensing, Inc. et al.
US8129431	March, 2015	FWD Entered (28 Jul, 2016)	Senju Pharmaceutical Co., Ltd.	InnoPharma, Licensing, Inc.
US8669290	March, 2015	Final Written Decision (28 Jul, 2016)	SENJU PHARMACEUTICAL CO., LTD. et al.	InnoPharma Licensing, Inc. et al.
US8669290	March, 2015	FWD Entered (28 Jul, 2016)	SENJU PHARMACEUTICAL CO., LTD.	InnoPharma Licensing, Inc.
US8669290	June, 2014	Terminated-Settled (08 Jul, 2015)	SENJU PHARMACEUTICAL CO., LTD.	Metrics, Inc.
US8129431	June, 2014	Terminated-Settled (08 Jul, 2015)	Senju Pharmaceutical Co., Ltd.	Metrics, Inc. c/o Duane Morris LLP
US6113906	October, 2006	Decision (05 Oct, 2006)	RICHARD B. GREENWALD et al
US5912238	November, 1997	Decision (19 Nov, 1997)	DONALD
US5955109	September, 1995	Decision (18 Sep, 1997)	WON et al

Bausch Drug Patents' Oppositions Filed in EPO

Bausch drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Jan 30, 2009, by Teva Pharmaceutical Industries Ltd.. This opposition was filed on patent number EP04702854A. Click below to reveal the latest opposition data.

Application	Filing Date	Opposition Party	Legal Status

EP20166312A	Feb, 2023	SANDOZ AG	Granted and Under Opposition
EP14791646A	Mar, 2022	European Oppositions Limited	Granted and Under Opposition
EP18209003A	Dec, 2020	Sandoz AG	Granted and Under Opposition
EP16704744A	Sep, 2019	European Oppositions Limited	Revoked
EP16704744A	Sep, 2019	Breuer, Markus	Revoked
EP16704744A	Sep, 2019	ALLERGAN, INC.	Revoked
EP04804405A	Nov, 2016	Teva Pharmaceutical Industries Ltd	Opposition rejected
EP04702854A	Jan, 2009	Teva Pharmaceutical Industries Ltd.	Opposition procedure closed

Bausch's Family Patents

Bausch drugs have patent protection in a total of 57 countries. It's US patent count contributes only to 40.4% of its total global patent coverage. 14 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Bausch Drug List

Given below is the complete list of Bausch's drugs and the patents protecting them.

1. Acanya

Acanya is protected by 7 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US8288434	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	05 Aug, 2029 (3 years from now)	Active
US10220049	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029 (3 years from now)	Active
US10624918	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029 (3 years from now)	Active
US8663699	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029 (3 years from now)	Active
US8895070	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029 (3 years from now)	Active
US9078870	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029 (3 years from now)	Active
US5733886	Compositions of clindamycin and benzoyl peroxide for acne treatment	31 Mar, 2015 (10 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Acanya's drug page

2. Aldara

Aldara is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US7696159 (Pediatric)	Treatment for basal cell carcinoma	01 Oct, 2024 (1 year, 3 months ago)	Expired
US7696159	Treatment for basal cell carcinoma	01 Apr, 2024 (1 year, 9 months ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Aldara's drug page

3. Alrex

Alrex is protected by 5 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US5540930 (Pediatric)	Suspension of loteprednol etabonate for ear, eye, or nose treatment	25 Apr, 2014 (11 years ago)	Expired
US5747061 (Pediatric)	Suspension of loteprednol etabonate for ear, eye, or nose treatment	25 Apr, 2014 (11 years ago)	Expired
US5540930	Suspension of loteprednol etabonate for ear, eye, or nose treatment	25 Oct, 2013 (12 years ago)	Expired
US5747061	Suspension of loteprednol etabonate for ear, eye, or nose treatment	25 Oct, 2013 (12 years ago)	Expired
US4996335 (Pediatric)	Soft steroids having anti-inflammatory activity	09 Sep, 2012 (13 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alrex's drug page

4. Aplenzin

Aplenzin is protected by 8 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US7241805	Modified release formulations of a bupropion salt	27 Jun, 2026 (5 months from now)	Active
US7569610	Modified release formulations of a bupropion salt	27 Jun, 2026 (5 months from now)	Active
US7572935	Modified release formulations of a bupropion salt	27 Jun, 2026 (5 months from now)	Active
US7585897	Modified release formulations of a bupropion salt	27 Jun, 2026 (5 months from now)	Active
US7645802	Bupropion hydrobromide and therapeutic applications	27 Jun, 2026 (5 months from now)	Active
US7649019	Modified release formulations of a bupropion salt	27 Jun, 2026 (5 months from now)	Active
US7662407	Modified release formulations of a bupropion salt	27 Jun, 2026 (5 months from now)	Active
US7671094	Bupropion hydrobromide and therapeutic applications	27 Jun, 2026 (5 months from now)	Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Aplenzin's drug page

5. Arazlo

Arazlo is protected by 4 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US11311482	Topical compositions and methods for treating skin diseases	11 May, 2038 (12 years from now)	Active
US12128137	Topical compositions and methods for treating skin diseases	11 May, 2038 (12 years from now)	Active
US11679116	Topical compositions and methods for treating psoriasis	06 Jun, 2036 (10 years from now)	Active
US6517847	Topical gel delivery system	03 Aug, 2020 (5 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Arazlo's drug page

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

6. Bepreve

Bepreve is protected by 3 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US8784789	Aqueous liquid preparations and light-stabilized aqueous liquid preparations	13 Jan, 2025 (11 months ago)	Expired
US8877168	Aqueous liquid preparations and light-stabilized aqueous liquid preparations	30 Jul, 2023 (2 years ago)	Expired
US6780877	Acid addition salt of optically active piperidine compound and process for preparing the same	19 Sep, 2019 (6 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Bepreve's drug page

7. Besivance

Besivance is protected by 7 patents, out of which 3 have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US8481526	Fluoroquinolone carboxylic acid molecular crystals	09 Jan, 2031 (5 years from now)	Active
US8415342	Besifloxacin ophthalmic composition for the treatment or control of infection	07 Nov, 2030 (4 years from now)	Active
US8604020	Fluoroquinolone carboxylic acid molecular crystals	12 Mar, 2030 (4 years from now)	Active
US8937062	Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria	13 Nov, 2029 (3 years from now)	Active
US6685958	Quinolone carboxylic acid compositions and related methods of treatment	29 Jun, 2021 (4 years ago)	Expired
US6699492	Quinolone carboxylic acid compositions and related methods of treatment	31 Mar, 2019 (6 years ago)	Expired
US5447926	Quinolone carboxylic acid derivatives	13 Apr, 2016 (9 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Besivance's drug page

8. Bryhali

Bryhali is protected by 7 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US10478502	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031 (5 years from now)	Active
US11839656	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031 (5 years from now)	Active
US11957753	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031 (5 years from now)	Active
US11986527	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031 (5 years from now)	Active
US12076403	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031 (5 years from now)	Active
US8809307	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031 (5 years from now)	Active
US6517847	Topical gel delivery system	03 Aug, 2020 (5 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Bryhali's drug page

9. Cabtreo

Cabtreo is protected by 8 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US11389467	Topical compositions	28 Dec, 2040 (14 years from now)	Active
US12128059	Topical compositions	31 Jul, 2040 (14 years from now)	Active
US12133859	Topical compositions	31 Jul, 2040 (14 years from now)	Active
US12138278	Topical compositions	31 Jul, 2040 (14 years from now)	Active
US8288434	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	05 Aug, 2029 (3 years from now)	Active
US10220049	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029 (3 years from now)	Active
US10624918	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029 (3 years from now)	Active
US9561208	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029 (3 years from now)	Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cabtreo's drug page

10. Cardizem Cd

Cardizem Cd is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US5439689	Diltiazem formulation	08 Aug, 2012 (13 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cardizem Cd's drug page

11. Cardizem La

Cardizem La is protected by 3 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US6923984	Cushioning wax beads for making solid shaped articles	25 Feb, 2021 (4 years ago)	Expired
US7108866	Chronotherapeutic diltiazem formulations and the administration thereof	17 Dec, 2019 (6 years ago)	Expired
US5529791	Extended release form of diltiazem	25 Jun, 2013 (12 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cardizem La's drug page

12. Clindagel

Clindagel is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US6387383	Topical low-viscosity gel composition	03 Aug, 2020 (5 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Clindagel's drug page

13. Diastat

Diastat is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US5462740	Rectally-administered, epileptic-seizure-inhibiting composition	17 Sep, 2013 (12 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Diastat's drug page

14. Diastat Acudial

Diastat Acudial is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US5462740	Rectally-administered, epileptic-seizure-inhibiting composition	17 Sep, 2013 (12 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Diastat Acudial's drug page

15. Duobrii

Duobrii is protected by 11 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US10251895	Topical compositions and methods for treating psoriasis	06 Jun, 2036 (10 years from now)	Active
US10426787	Topical compositions and methods for treating psoriasis	06 Jun, 2036 (10 years from now)	Active
US11648256	Topical compositions and methods for treating psoriasis	06 Jun, 2036 (10 years from now)	Active
US11679115	Topical compositions and methods for treating psoriasis	06 Jun, 2036 (10 years from now)	Active
US10478502	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031 (5 years from now)	Active
US11839656	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031 (5 years from now)	Active
US11957753	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031 (5 years from now)	Active
US11986527	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031 (5 years from now)	Active
US12076403	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031 (5 years from now)	Active
US8809307	Pharmaceutical formulations containing corticosteroids for topical administration	02 Nov, 2031 (5 years from now)	Active
US6517847	Topical gel delivery system	03 Aug, 2020 (5 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Duobrii's drug page

16. Elidel

Elidel is protected by 6 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US6423722 (Pediatric)	Crystalline macrolides and process for their preparation	26 Dec, 2018 (7 years ago)	Expired
US6423722	Crystalline macrolides and process for their preparation	26 Jun, 2018 (7 years ago)	Expired
US5912238 (Pediatric)	Heteroatoms-containing tricyclic compounds	15 Dec, 2016 (9 years ago)	Expired
US5912238	Heteroatoms-containing tricyclic compounds	15 Jun, 2016 (9 years ago)	Expired
US6352998 (Pediatric)	Pharmaceutical compositions	26 Apr, 2016 (9 years ago)	Expired
US6352998	Pharmaceutical compositions	26 Oct, 2015 (10 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Elidel's drug page

17. Fluorescein Sodium And Benoxinate Hydrochloride

Fluorescein Sodium And Benoxinate Hydrochloride is protected by 3 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US10293047	Fluorescein and benoxinate compositions	15 Nov, 2037 (11 years from now)	Active
US10632197	Fluorescein and benoxinate compositions	15 Nov, 2037 (11 years from now)	Active
US10842872	Fluorescein and benoxinate compositions	15 Nov, 2037 (11 years from now)	Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Fluorescein Sodium And Benoxinate Hydrochloride's drug page

18. Istalol

Istalol is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US6645963	Prolonged-action eye drop	16 Nov, 2018 (7 years ago)	Expired
US6335335	Prolonged-action eye drop	02 Nov, 2018 (7 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Istalol's drug page

19. Jublia

Jublia is protected by 18 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US10478601	Applicator	25 Apr, 2035 (9 years from now)	Active
US10342875	Stabilized efinaconazole compositions	02 Oct, 2034 (8 years from now)	Active
US10828293	Anti-infective methods, compositions, and devices	02 Oct, 2034 (8 years from now)	Active
US10864274	Stabilized efinaconazole formulations	02 Oct, 2034 (8 years from now)	Active
US11654139	Anti-infective methods, compositions, and devices	02 Oct, 2034 (8 years from now)	Active
US9662394	Stabilized efinaconazole compositions	02 Oct, 2034 (8 years from now)	Active
US8486978	Compositions and methods for treating diseases of the nail	24 Oct, 2030 (4 years from now)	Active
US9302009	Compositions and methods for treating diseases of the nail	24 Oct, 2030 (4 years from now)	Active
US10105444	Compositions and methods for treating diseases of the nail	08 Jul, 2030 (4 years from now)	Active
US8039494	Compositions and methods for treating diseases of the nail	08 Jul, 2030 (4 years from now)	Active
US9861698	Compositions and methods for treating diseases of the nail	08 Jul, 2030 (4 years from now)	Active
US10512640	Compositions and methods for treating diseases of the nail	03 Jan, 2028 (1 year, 11 months from now)	Active
US10828369	Compositions and methods for treating diseases of the nail	03 Jan, 2028 (1 year, 11 months from now)	Active
US11213519	Compositions and methods for treating diseases of the nail	03 Jan, 2028 (1 year, 11 months from now)	Active
US11872218	Compositions and methods for treating diseases of the nail	03 Jan, 2028 (1 year, 11 months from now)	Active
US9566272	Compositions and methods for treating diseases of the nail	03 Jan, 2028 (1 year, 11 months from now)	Active
US9877955	Compositions and methods for treating diseases of the nail	03 Jan, 2028 (1 year, 11 months from now)	Active
US7214506	Method for treating onychomycosis	22 Feb, 2026 (a month from now)	Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Jublia's drug page

20. Locoid

Locoid is protected by 2 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US7378405	Stabilized steroid composition and method for its preparation	19 Dec, 2026 (11 months from now)	Active
US7981877	Stabilized steroid composition and method for its preparation	23 Jan, 2025 (11 months ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Locoid's drug page

21. Loprox

Loprox is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US7981909	Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis	16 Sep, 2017 (8 years ago)	Expired
US8227490	Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis	16 Sep, 2017 (8 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Loprox's drug page

22. Lotemax

Lotemax is protected by 6 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US5800807	Ophthalmic compositions including glycerin and propylene glycol	29 Jan, 2017 (8 years ago)	Expired
US5540930 (Pediatric)	Suspension of loteprednol etabonate for ear, eye, or nose treatment	25 Apr, 2014 (11 years ago)	Expired
US5747061 (Pediatric)	Suspension of loteprednol etabonate for ear, eye, or nose treatment	25 Apr, 2014 (11 years ago)	Expired
US5540930	Suspension of loteprednol etabonate for ear, eye, or nose treatment	25 Oct, 2013 (12 years ago)	Expired
US5747061	Suspension of loteprednol etabonate for ear, eye, or nose treatment	25 Oct, 2013 (12 years ago)	Expired
US4996335 (Pediatric)	Soft steroids having anti-inflammatory activity	09 Sep, 2012 (13 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lotemax's drug page

23. Lotemax Sm

Lotemax Sm is protected by 2 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US10596107	Ophthalmic suspension composition	23 Dec, 2036 (10 years from now)	Active
US11534395	Ophthalmic suspension composition	26 Jan, 2036 (10 years from now)	Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lotemax Sm's drug page

24. Lumify

Lumify is protected by 4 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US8293742	Preferential vasoconstriction compositions and methods of use	14 Jul, 2030 (4 years from now)	Active
US9259425	Compositions and methods for eye whitening	14 Jul, 2030 (4 years from now)	Active
US11596600	Vasoconstriction compositions and methods of use	27 Jul, 2029 (3 years from now)	Active
US11833245	Vasoconstriction compositions and methods of use	27 Jul, 2029 (3 years from now)	Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lumify's drug page

25. Lumify Preservative Free

Lumify Preservative Free is protected by 3 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US8293742	Preferential vasoconstriction compositions and methods of use	14 Jul, 2030 (4 years from now)	Active
US9259425	Compositions and methods for eye whitening	14 Jul, 2030 (4 years from now)	Active
US11596600	Vasoconstriction compositions and methods of use	27 Jul, 2029 (3 years from now)	Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lumify Preservative Free's drug page

26. Luzu

Luzu is protected by 5 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US8980931	Method of evaluating pharmaceutical preparation containing luliconazole and index substance	28 Apr, 2034 (8 years from now)	Active
US9012484	Crystal and pharmaceutical preparation containing the same crystal	06 Sep, 2033 (7 years from now)	Active
US9199977	Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal	06 Sep, 2033 (7 years from now)	Active
US9453006	Crystalline form having specific crystal habit and pharmaceutical composition containing this crystalline form as active ingredient	06 Sep, 2033 (7 years from now)	Active
US5900488	Method for treating mycosis using imidazolylacetonitrile derivatives	18 Jan, 2020 (5 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Luzu's drug page

27. Macugen

Macugen is protected by 5 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US6011020	Nucleic acid ligand complexes	04 Jan, 2017 (9 years ago)	Expired
US5932462	Multiarmed, monofunctional, polymer for coupling to molecules and surfaces	03 Aug, 2016 (9 years ago)	Expired
US6051698	Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes	19 May, 2015 (10 years ago)	Expired
US5919455	Non-antigenic branched polymer conjugates	27 Oct, 2013 (12 years ago)	Expired
US6113906	Water-soluble non-antigenic polymer linkable to biologically active material	27 Oct, 2013 (12 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Macugen's drug page

28. Metrogel-vaginal

Metrogel-vaginal is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US5536743	Intravaginal treatment of vaginal infections with buffered metronidazole compositions	16 Jul, 2013 (12 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Metrogel-vaginal's drug page

29. Miebo

Miebo is protected by 6 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US10507132	Topical administration method	21 Jun, 2037 (11 years from now)	Active
US11357738	Semifluorinated compounds and their compositions	29 Sep, 2036 (10 years from now)	Active
US10058615	Semifluorinated alkane compositions	12 Sep, 2033 (7 years from now)	Active
US10369117	Compositions comprising mixtures of semifluorinated alkanes	12 Sep, 2033 (7 years from now)	Active
US10449164	Methods of treating ocular disorders using semifluorinated alkanes	12 Sep, 2033 (7 years from now)	Active
US10576154	Semifluorinated alkane compositions	12 Sep, 2033 (7 years from now)	Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Miebo's drug page

30. Miochol-e

Miochol-e is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US6261546	Methods and compositions for stabilizing acetylcholine compositions	29 Apr, 2019 (6 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Miochol-e's drug page

31. Onexton

Onexton is protected by 6 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US8288434	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	05 Aug, 2029 (3 years from now)	Active
US10137142	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029 (3 years from now)	Active
US10220049	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029 (3 years from now)	Active
US9504704	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029 (3 years from now)	Active
US9561208	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	03 Jun, 2029 (3 years from now)	Active
US5733886	Compositions of clindamycin and benzoyl peroxide for acne treatment	31 Mar, 2015 (10 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Onexton's drug page

32. Prolensa

Prolensa is protected by 9 patents, out of which 7 have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US9517220	Bromfenac bioavailability	11 Nov, 2033 (7 years from now)	Active
US10085958	Bromfenac bioavailability	19 Nov, 2032 (6 years from now)	Active
US8129431	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	11 Sep, 2025 (3 months ago)	Expired
US8669290	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	16 Jan, 2024 (1 year, 11 months ago)	Expired
US8754131	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	16 Jan, 2024 (1 year, 11 months ago)	Expired
US8871813	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	16 Jan, 2024 (1 year, 11 months ago)	Expired
US8927606	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	16 Jan, 2024 (1 year, 11 months ago)	Expired
US9144609	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	16 Jan, 2024 (1 year, 11 months ago)	Expired
US9561277	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	16 Jan, 2024 (1 year, 11 months ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prolensa's drug page

33. Retin-a Micro

Retin-a Micro is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US5955109	Methods and compositions for topical delivery of retinoic acid	21 Sep, 2016 (9 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Retin-a Micro's drug page

34. Retin-a-micro

Retin-a-micro is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US5955109	Methods and compositions for topical delivery of retinoic acid	21 Sep, 2016 (9 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Retin-a-micro's drug page

35. Retisert

Retisert is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US6217895	Method for treating and/or preventing retinal diseases with sustained release corticosteroids	22 Mar, 2019 (6 years ago)	Expired
US6548078	Method for treating and/or preventing retinal diseases with sustained release corticosteroids	22 Mar, 2019 (6 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Retisert's drug page

36. Solodyn

Solodyn is protected by 9 patents, out of which 5 have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US9192615	Method for the treatment of acne and certain dosage forms thereof	17 Nov, 2031 (5 years from now)	Active
US7541347	Minocycline oral dosage forms for the treatment of acne	02 Apr, 2027 (1 year, 2 months from now)	Active
US7544373	Minocycline oral dosage forms for the treatment of acne	02 Apr, 2027 (1 year, 2 months from now)	Active
US7919483	Method for the treatment of acne	07 Mar, 2027 (1 year, 1 month from now)	Active
US7790705	Minocycline oral dosage forms for the treatment of acne	24 Jun, 2025 (6 months ago)	Expired
US8252776	Minocycline oral dosage forms for the treatment of acne	24 Jun, 2025 (6 months ago)	Expired
US8268804	Minocycline oral dosage forms for the treatment of acne	24 Jun, 2025 (6 months ago)	Expired
US8722650	Extended-release minocycline dosage forms	24 Jun, 2025 (6 months ago)	Expired
US5908838	Method for the treatment of acne	19 Feb, 2018 (7 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Solodyn's drug page

37. Targretin

Targretin is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US5962731	Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors	05 Oct, 2016 (9 years ago)	Expired
US5780676	Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors	14 Jul, 2015 (10 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Targretin's drug page

38. Tasmar

Tasmar is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US5476875	Catechol derivatives	19 Dec, 2012 (13 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tasmar's drug page

39. Tiazac

Tiazac is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US5529791	Extended release form of diltiazem	25 Jun, 2013 (12 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tiazac's drug page

40. Vanos

Vanos is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US8232264	Compositions and methods for enhancing corticosteroid delivery	09 Mar, 2023 (2 years ago)	Expired
US7220424	Compositions and methods for enhancing corticosteroid delivery	07 Jan, 2023 (3 years ago)	Expired
US7794738	Compositions and methods for enhancing corticosteroid delivery	11 Sep, 2022 (3 years ago)	Expired
US6765001	Compositions and methods for enhancing corticosteroid delivery	21 Dec, 2021 (4 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vanos's drug page

41. Virazole

Virazole is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US6150337	Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes	21 Nov, 2017 (8 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Virazole's drug page

42. Visudyne

Visudyne is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US5756541	Vision through photodynamic therapy of the eye	11 Mar, 2016 (9 years ago)	Expired
US5798349	Use of green porphyrins to treat neovasculature in the eye	25 Aug, 2015 (10 years ago)	Expired
US5707608	Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer	02 Aug, 2015 (10 years ago)	Expired
US5770619	Method of activating photosensitive agents	06 Jan, 2015 (11 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Visudyne's drug page

43. Vyzulta

Vyzulta is protected by 5 patents, out of which 4 have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US8058467	Prostaglandin derivatives	21 Feb, 2029 (3 years from now)	Active
US7273946	Prostaglandin derivatives	03 Oct, 2025 (3 months ago)	Expired
US7629345	Prostaglandin derivatives	05 Jan, 2025 (1 year, 3 days ago)	Expired
US7910767	Prostaglandin derivatives	05 Jan, 2025 (1 year, 3 days ago)	Expired
US6211233	Prostaglandin pharmaceutical compositions	17 Jun, 2018 (7 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vyzulta's drug page

44. Wellbutrin Xl

Wellbutrin Xl is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US6096341	Delayed release tablet of bupropion hydrochloride	30 Oct, 2018 (7 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Wellbutrin Xl's drug page

45. Xerese

Xerese is protected by 3 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US7223387	Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester	28 Feb, 2021 (4 years ago)	Expired
US6514980	Nucleoside analogs in combination therapy of herpes simplex infections	24 Jan, 2017 (8 years ago)	Expired
USRE39264	Pharmaceutical combination	02 Feb, 2016 (9 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xerese's drug page

46. Xiidra

Xiidra is protected by 16 patents, out of which 6 have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US11058677	LFA-1 inhibitor formulations	18 Dec, 2033 (7 years from now)	Active
US9085553	LFA-1 inhibitor and methods of preparation and polymorph thereof	25 Jul, 2033 (7 years from now)	Active
US8927574	Crystalline pharmaceutical and methods of preparation and use thereof	12 Nov, 2030 (4 years from now)	Active
US9353088	Crystalline pharmaceutical and methods of preparation and use thereof	21 Oct, 2030 (4 years from now)	Active
US9890141	Crystalline pharmaceutical and methods of preparation and use thereof	21 Oct, 2030 (4 years from now)	Active
US8168655	Compositions and methods for treatment of eye disorders	09 May, 2029 (3 years from now)	Active
US8367701	Crystalline pharmaceutical and methods of preparation and use thereof	15 Apr, 2029 (3 years from now)	Active
US9447077	Crystalline pharmaceutical and methods of preparation and use thereof	15 Apr, 2029 (3 years from now)	Active
US8084047	Compositions and methods for treatment of eye disorders	17 May, 2026 (4 months from now)	Active
US8592450	Compositions and methods for treatment of eye disorders	17 May, 2026 (4 months from now)	Active
US7314938	Modulators of cellular adhesion	10 Mar, 2025 (9 months ago)	Expired
US10124000	Modulators of cellular adhesion	05 Nov, 2024 (1 year, 2 months ago)	Expired
US7745460	Modulators of cellular adhesion	05 Nov, 2024 (1 year, 2 months ago)	Expired
US7790743	Modulators of cellular adhesion	05 Nov, 2024 (1 year, 2 months ago)	Expired
US7928122	Modulators of cellular adhesion	05 Nov, 2024 (1 year, 2 months ago)	Expired
US9216174	Modulators of cellular adhesion	05 Nov, 2024 (1 year, 2 months ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xiidra's drug page

47. Xipere

Xipere is protected by 4 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US12419833		16 Apr, 2040 (14 years from now)	Active
US9937075	Apparatus and methods for ocular injection	02 May, 2034 (8 years from now)	Active
US9636332	Methods and devices for the treatment of ocular diseases in human subjects	08 Nov, 2033 (7 years from now)	Active
US8636713	Methods and devices for drug delivery to ocular tissue using microneedle	02 May, 2027 (1 year, 3 months from now)	Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xipere's drug page

48. Zelapar

Zelapar is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US6423342	Process for the preparation of a solid pharmaceutical dosage form	01 Mar, 2016 (9 years ago)	Expired
US5648093	Pharmaceutical and other dosage forms	15 Jul, 2014 (11 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zelapar's drug page

49. Ziana

Ziana is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US6387383	Topical low-viscosity gel composition	03 Aug, 2020 (5 years ago)	Expired
USRE41134	Slow release vehicles for minimizing skin irritancy of topical compositions	24 Feb, 2015 (10 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ziana's drug page

50. Zyclara

Zyclara is protected by 10 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US10918635	Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts	30 Apr, 2030 (4 years from now)	Active
US11202752	Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy	30 Apr, 2030 (4 years from now)	Active
US11850245	Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts	30 Apr, 2030 (4 years from now)	Active
US10238644	2×2×2 week dosing regimen for treating acting keratosis with pharmaceutical compositions formulated with 3.75% imiquimod	11 Dec, 2029 (3 years from now)	Active
US11318130	2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75% imiquimod	11 Dec, 2029 (3 years from now)	Active
US8222270	2×2×2 week treatment regimen for treating actinic keratosis with pharmaceutical compositions formulated with 2.5% imiquimod	11 Dec, 2029 (3 years from now)	Active
US8236816	2×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod	11 Dec, 2029 (3 years from now)	Active
US8299109	Method of treating actinic keratosis with 3.75% imiquimod cream	11 Dec, 2029 (3 years from now)	Active
US10238645	Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts	18 Aug, 2029 (3 years from now)	Active
US8598196	Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy	18 Aug, 2029 (3 years from now)	Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zyclara's drug page

51. Zylet

Zylet is protected by 5 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status
US5540930 (Pediatric)	Suspension of loteprednol etabonate for ear, eye, or nose treatment	25 Apr, 2014 (11 years ago)	Expired
US5747061 (Pediatric)	Suspension of loteprednol etabonate for ear, eye, or nose treatment	25 Apr, 2014 (11 years ago)	Expired
US5540930	Suspension of loteprednol etabonate for ear, eye, or nose treatment	25 Oct, 2013 (12 years ago)	Expired
US5747061	Suspension of loteprednol etabonate for ear, eye, or nose treatment	25 Oct, 2013 (12 years ago)	Expired
US4996335 (Pediatric)	Soft steroids having anti-inflammatory activity	09 Sep, 2012 (13 years ago)	Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zylet's drug page

Pharsight

Pharsight

Latest Legal Activities on Bausch's Drug Patents

Bausch's Drug Patent Litigations

Bausch Drug Patents' Oppositions Filed in EPO

Bausch's Family Patents

Bausch Drug List

Explore Our Curated Drug Screens

Bausch News

Related content

Have Questions?